<DOC>
	<DOCNO>NCT00548223</DOCNO>
	<brief_summary>In order observe secondary preventive effect Dengzhanshengmai capsule ischemic stroke , investigator hold large randomize control trial ( RCT ) . 3143 subject include 83 clinical research center China . The subject randomly group two group . The basic therapy include antiplatelet aggregation , stroke health education , management blood pressure , blood lipid blood glucose , etc . The treat group take compound Chinese Medicine Deng Zhan Sheng Mai capsule contrast group take placebo twelve month . Then subject visited 30th , 90th , 180th , 360th day inclusion . The recurrence stroke , cardiovascular event , peripheral arterial event observe .</brief_summary>
	<brief_title>The Secondary Prevention Trial Ischemic Stroke With DengzhanShengmai Capsule</brief_title>
	<detailed_description>Objective : To observe secondary clinical effect Deng Zhan Sheng Mai capsule ischemic stroke patient . Methods:3143 subject suffer acute ischemic stroke include 83 clinical research center China . The subject randomly divide two group : The treat group placebo group.Both group accept basic therapy test drug.The basic therapy include antiplatelet aggregation , stroke health education , management blood pressure , blood lipid blood glucose , etc.The patient Dengzhan Shengmaigroup take Deng Zhan Sheng Mai capsule placebo group take placebo drug twelve months.Then subject visit 30th,90th,180th,360th day inclusion . Primary endpoint ( cerebral infarction , intracerebral hemorrhage , subarachnoid hemorrhage ) secondary endpoint ( cardiovascular event , peripheral arterial disease ) , functional disability observe follow .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>4075 year old Ischemic stroke diagnose CT/MRI scan Patient present 14 day 6 month first onset ischemic stroke Presence least one risk factor stroke ( hypertension , diabetes mellitus , coronary heart disease , hyperlipidemia , smoking , etc . ) interfere Informed consent Silent cerebral infarction Cerebral infarction due cause except artery sclerosis ( i.e . cardiogenic embolism , hypercoagulable state , endangium stripping , vasculitis ) Presence serious heart disease , heart , liver , lung , kidney functional failure ; malignancy ; alimentary tract hemorrhage mental disorder noncooperation physician Females pregnancy lactation Already attend clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>recurrence stroke</keyword>
	<keyword>Dengzhan Shengmai Capsule</keyword>
	<keyword>Traditional Chinese Medicine</keyword>
</DOC>